AM2: APRAMYCIN
AM2 is a Ligand Of Interest in 6MN4 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
| 6MN4_AM2_A_301 | 39% | 22% | 0.142 | 0.849 | 1.66 | 1.5 | 8 | 7 | 2 | 0 | 100% | 0.96 |
| 6MN4_AM2_B_301 | 32% | 21% | 0.159 | 0.836 | 1.73 | 1.5 | 6 | 10 | 9 | 0 | 100% | 0.98 |
| 6MN4_AM2_D_301 | 15% | 24% | 0.203 | 0.773 | 1.7 | 1.33 | 6 | 6 | 3 | 0 | 100% | 0.9 |
| 6MN4_AM2_C_301 | 14% | 29% | 0.167 | 0.725 | 1.63 | 1.13 | 7 | 3 | 5 | 0 | 100% | 0.97 |
| 6MN4_AM2_E_301 | 4% | 23% | 0.227 | 0.618 | 1.68 | 1.43 | 8 | 6 | 2 | 0 | 100% | 0.9 |
| 6MN4_AM2_F_301 | 2% | 22% | 0.254 | 0.549 | 1.67 | 1.48 | 7 | 6 | 5 | 0 | 100% | 0.8 |
| 4K31_AM2_C_101 | 99% | 60% | 0.047 | 0.992 | 0.4 | 0.96 | - | 2 | 0 | 0 | 100% | 1 |
| 2G5K_AM2_A_102 | 98% | 28% | 0.051 | 0.984 | 1.71 | 1.1 | 12 | 4 | 0 | 0 | 100% | 1 |
| 7KES_AM2_B_305 | 97% | 61% | 0.058 | 0.979 | 0.45 | 0.89 | - | 2 | 5 | 0 | 100% | 1 |
| 7JM2_AM2_B_301 | 82% | 33% | 0.073 | 0.93 | 1.53 | 1.05 | 6 | 4 | 0 | 0 | 100% | 1 |
| 2OE5_AM2_B_101 | 80% | 29% | 0.076 | 0.927 | 1.58 | 1.19 | 11 | 4 | 0 | 0 | 100% | 1 |